Showing results (41-50 of 498) with videos related to

Sort By:
Pageof 50
Mediterranean Journal of Hematology and Infectious Diseases|June 19, 2012
Bortezomib a safe treatment for patients with multiple myeloma and cystic fibrosisFabiana Gentilini, Anna Levi, Vincenzo Federico, et al.
European Journal of Haematology|December 16, 2011
Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian familyArturo Cafolla, Giovanna D'Andrea, Erminia Baldacci, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|March 21, 2022
[Reliability and validity of the OPD-conflict-questionnaire in an inpatient treatment sample]Miriam Henkel, Cord Benecke, Oliver Masuhr, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|August 11, 2007
[The effectiveness of psychoanalytic-interactional therapy in borderline personality disorder: a study of clinical data]Falk Leichsenring, Oliver Masuhr, Ulrich Jaeger, et al.
Bulletin of the Menninger Clinic|October 8, 2010
The effectiveness of psychoanalytic-interactional psychotherapy in borderline personality disorderFalk Leichsenring, Oliver Masuhr, Ulrich Jaeger, et al.
The Journal of Experimental Medicine|January 10, 2002
V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sitesRodrig Marculescu, Trang Le, Paul Simon, et al.
Psychotherapy Research : Journal of the Society for Psychotherapy Research|October 9, 2024
First impressions count: Therapists' impression on patients' motivation and helping alliance predicts psychotherapy dropoutKristin Jankowsky, Johannes Zimmermann, Ulrich Jaeger, et al.
Cancer Journal (Sudbury, Mass.)|August 16, 2021
COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand NowThomas Chatzikonstantinou, Yair Herishanu, Emili Montserrat, et al.
Haematologica|January 12, 2005
Is bone marrow trephine biopsy always mandatory in staging Hodgkin's disease?Elena Cavalieri, Anna Paola Anselmo, Valentina Gianfelici, et al.
Expert Review of Hematology|November 18, 2020
Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practiceMassimo Breccia, Fabio Efficace, Gioia Colafigli, et al.
Pageof 50